Galectin-9 Ameliorates Con A-Induced Hepatitis by Inducing CD4+CD25low/int Effector T-Cell Apoptosis and Increasing Regulatory T Cell Number

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Lv, Kun ^a   Zhang, Yingying ^a   Zhang, Mengying ^a   Zhong, Min ^a   Suo, Qifeng ^a  

^a WANNAN MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA GALACTOSIDASE; CASPASE 3; CONCANAVALIN A; ECALECTIN; GAMMA INTERFERON; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DNA FRAGMENTATION; DRUG ACTIVITY; DRUG EFFICACY; EFFECTOR CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; HEPATITIS; IMMUNE RESPONSE; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MOUSE; NECROSIS; NONHUMAN; PROTEIN CLEAVAGE; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH1 CELL;

ANIMALS; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CONCANAVALIN A; CYTOKINES; GALECTINS; HEPATITIS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, REGULATORY;

ANIMALIA; MUS;

EID: 84868267018     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048379     Document Type: Article

References (32)

1. Kern M, Popov A, Scholz K, Schumak B, Djandji D, et al. (2010) Virally infectedmouse liver endothelial cells trigger CD8+ T-cell immunity. Gastroenterology 138: 336-346.
2. Park EJ, Lee JH, Yu GY, He G, Ali SR, et al. (2010) Dietary and genetic obesitypromote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140: 197-208.
3. Wang H, Park O, Lafdil F, Shen K, Horiguchi N, et al. (2010) Interplay of hepatic andmyeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity. Hepatology 51: 1354-1362.
4. Bird L, (2010) T cell responses: IL-2 overrules tolerogenic liver responses. Nat Rev Immunol 10: 289.
5. Tiegs G, Hentshel J, Wendel A, (1992) A T cell-dependent experimental liver injury in mice induced by Concanavalin A. J Clin Invest. 90: 196-203.
6. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, et al. (1994) T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 179: 1529-1537.
7. Nakaya M, Hashimoto M, Nakagawa R, Wakabayashi Y, Ishizaki T, et al. (2009) SOCS3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA induced hepatitis. J Immunol 183: 7047-7053.
8. Mizuhara H, Uno M, Seki N, Yamashita M, Yamaoka M, et al. (1996) Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 23: 1608-1615.
9. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G, (1995) Concanavalin A-induced T-cell mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21: 190-198.
10. Kusters S, Gantner F, Kunstle G, Tiegs G, (1996) Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by Concanavalin A. Gastroenterology. 111: 462-471.
11. Mizuhara H, Uno M, Seki N, Yamashita M, Yamaoka M, et al. (1996) Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 23: 1608-1615.
12. Tagawa Y, Sekikawa K, Iwakura Y, (1997) Suppression of Concanavalin Ainduced hepatitis in IFN-g-/- mice, but not in TNF-a-/- mice. J Immunol 159: 1418-1428.
13. Saita N, Goto E, Yamamoto T, Cho I, Tsumori K, et al. (2002) Association of galectin-9 with eosinophil apoptosis. Int Arch Allergy Immunol. 128: 42-50.
14. Kageshita T, Kashio Y, Yamauchi A, Seki M, AbedinM J, et al. (2002) Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer 99: 809-816.
15. Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS, (1997) Developmental regulation, expression, and apoptotic potential of galectin-9, a b-galactoside binding lectin. J Clin Invest 99: 2452-2461.
16. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, et al. (1998) Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 273: 16976-16984.
17. Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, et al. (2003) Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 170: 3631-3636.
18. Boenisch O, D'Addio F, Watanabe T, Elyaman W, Ciara NM, et al. (2010) TIM-3: A Novel Regulatory Molecule of Alloimmune Activation. J Immunol 185: 5806-5819.
19. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, et al. (2005) The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6: 1245-1252.
20. Valerie D, Anderson AC, Karman J, Apetoh L, Chandwaskar R, et al. (2010) Tim-3/Galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. J Immunol 185: 1383-1392.
21. Tsuboi Y, Abe H, Nakagawa R, Oomizu S, Watanabe K, et al. (2007) Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2- producing polymorphonuclear leukocytes. Clin Immunol 124: 221-233.
22. Fukushima A, Tamaki S, Ken F, (2008) Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice. Int Arch Allergy Immunol 146: 36-43.
23. Seki M, Oomizu S, Sakata K, Sakata A, Arikawa T, et al. (2008) Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127: 78-88.
24. Sharvan S, Amol S, Hirashima M, Rouse BT, (2009) Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J Immunol 182: 3191-3201.
25. Lv K, Xu W, Wang CN, Niki T, Hirashima M, et al. (2011) Galectin-9 administration ameliorates CVB3 induced myocarditis by promoting the proliferation of regulatory T cells and alternatively activated Th2 cells. Clin Immunol 140: 92-101.
26. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S, (1997) Essential roles of the Fas ligand in the development of hepatitis. Nature Med 3: 409-413.
27. Seino KI, Kayagaki N, Takeda K, Fukao K, Okumura K, et al. (1997) Contribution of Fas ligand to cell-mediated hepatic injury in mice. Gastroenterology 113: 1315-1322.
28. Nagata T, McKinley L, Peschon JJ, Alcorn JF, Aujla SJ, et al. (2008) Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells. J Immunol 181: 7473-7479.
29. Morita M, Watanabe Y, Akaike T, (1995) Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes. Hepatology 21: 1585-1593.
30. Shinagawa T, Yoshioka K, Kakumu S, Wakita T, Ishikawa T, et al. (1995) Apoptosis in cultured rat hepatocytes: the effects of tumor necrosis factor a and interferon g. J Pathol 165: 247-253.
31. Tiegs G, (1998) Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology 114: 1035-1045.
32. Rodriguez I, Matsuura K, Ody C, Nagata S, Vassalli P, (1996) Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction. J Exp Med 184: 2067-2072.